The Comparison of the Premenstrual Syndrome Patients with and without COVID-19 History

Aim: The term premenstrual syndrome (PMS) is used to define somatic, cognitive, emotional, and behavioural disorders that emerge during the luteal phase of the menstrual cycle and rapidly recover with the onset of menstruation. The aim of this study was to investigate PMS symptoms in women who were sensitive psychosocially because of pandemic restrictions. Material and Methods: The study included a total of 187 women aged 18-50 years who presented at the Gynaecology and Obstetrics Department of Turhal State Hospital between June 2021 and August 2021. The women were separated into two groups as 66 who had contracted and recovered from COVID-19 infection within the previous 6 months and 121 who had not had COVID-19 infection. The PMS Scale was applied to all the patients. Results: The rates of complaints of changes in appetite (p=0.004), depressive mood (p=0.002), depressive thoughts (p=0.001), fatigue (p=0.001), changes in sleep (p=0.002), anxiety (p=0.036) and menstrual irregularity (p=0.003) were determined to be statistically significantly higher in the COVID-19 group compared to the group that had not had COVID-19. Conclusion: The PMS complaints of changes in appetite, depressive mood, depressive thoughts, fatigue, changes in sleep, anxiety and menstrual irregularity were experienced more in the women who had had COVID-19. Therefore, the PMS complaints of women during the COVID-19 pandemic should be listened to carefully and it must be taken into consideration that these can be more significant in patients who have contracted COVID-19 infection. .